Bitcoin price today: gains to $120k, near record high on U.S. regulatory cheer
MILPITAS, Calif. - Amazfit, a brand under Zepp Health (NYSE:ZEPP), unveiled its latest smartwatch, the Amazfit Bip 6, tailored for fitness enthusiasts. With a market capitalization of $45 million and annual revenue of $182.6 million, Zepp Health continues to expand its product lineup. The new device sports a 1.97-inch AMOLED display, advanced health tracking capabilities, and boasts a two-week battery life.
The Bip 6, priced at $79.99, aims to blend functionality with affordability, featuring a lightweight aluminum design, 5 ATM water resistance, and a selection of four colors. It is equipped with Amazfit’s BioTracker™ 6.0 PPG biometric sensor, providing detailed data on heart rate, blood oxygen levels, and stress, among other health metrics.
Supporting over 140 workout modes, the smartwatch includes features like Smart Strength Training and offline navigation for outdoor activities. Users can also receive on-wrist notifications, make calls, send voice-to-text messages, and control music and the camera on their iPhone through a Bluetooth connection. According to InvestingPro, Zepp Health’s stock has shown strong momentum with a 15.38% gain year-to-date, despite recent market volatility. Discover more insights and 11 additional ProTips with an InvestingPro subscription.
The accompanying Zepp App enhances the user experience by offering a centralized platform for tracking health and fitness data. It also introduces a camera-powered food log feature, currently available in several countries including the United States and the UK, which allows meal tracking by simply photographing food.
The Amazfit Bip 6 is available for purchase on the Amazfit website and Amazon. This launch is part of Amazfit’s ongoing effort to provide accessible health and fitness technology to a global customer base. Based on InvestingPro’s Fair Value analysis, Zepp Health currently appears undervalued, suggesting potential upside for investors interested in the wearable technology sector. The information for this article is based on a press release statement and InvestingPro data.
In other recent news, Zepp Health Corp reported a notable 40% increase in Q4 2024 sales compared to the previous quarter. Despite the growth in sales, the company’s full-year revenue experienced a decline, largely attributed to reduced sales of Xiaomi products and fewer new product launches. The company has provided revenue guidance for Q1 2025, estimating between $40 million and $45 million, which suggests a potential year-over-year growth of 14-29%. Zepp Health has also improved its full-year 2024 gross margin to 39%, up from 26.2% in 2023. The company is focusing on AI integration and new product launches, planning to introduce one to two new products each quarter in 2025.
Additionally, Zepp Health is undergoing a strategic shift from an OEM to a branded smartwatch company, similar to Garmin. This transformation includes the launch of new products like the T Rex3, which has been positively received in the market. The company also announced a cash balance of $112 million at the end of 2024, providing a solid foundation for future investments. Analysts from Fundamental Research Corp noted Zepp Health’s proactive supply chain management, which minimizes the impact of new U.S. tariffs on Chinese smartwatch imports. Looking forward, Zepp Health aims to maintain its growth trajectory by expanding its product offerings and focusing on AI-driven health solutions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.